Clinical Trial Update: Prasugrel for Prevention of Early Saphenous Vein Graft Thrombosis [Phase 3]

View source ↗

Summary

Phase 3 trial update on prasugrel for prevention of early saphenous vein graft thrombosis in coronary artery bypass patients; results completed with postings in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Bypass Graft Disease
• Coronary Artery Disease

Drugs mentioned

• PRASUGREL (prasugrel)

Snippet

Sponsor: VA Office of Research and Development | Conditions: Coronary Artery Bypass | Phase 3 | Status: COMPLETED | Results posted: 2019-10-09